Transient regulation of focal adhesion via Tensin3 is required for nascent oligodendrocyte differentiation

  1. Emeric Merour
  2. Hatem Hmidan
  3. Corentine Marie
  4. Pierre-Henri Helou
  5. Haiyang Lu
  6. Antoine Potel
  7. Jean-Baptiste Hure
  8. Adrien Clavairoly
  9. Yi Ping Shih
  10. Salman Goudarzi
  11. Sebastien Dussaud
  12. philippe Ravassard
  13. Sassan Hafizi
  14. Su Hao Lo
  15. Bassem A Hassan
  16. Carlos Parras  Is a corresponding author
  1. Sorbonne Université, Inserm U1127, CNRS UMR 7225, France
  2. University of California, Davis, United States
  3. University of Portsmouth, United Kingdom

Abstract

The differentiation of oligodendroglia from oligodendrocyte precursor cells (OPCs) to complex and extensive myelinating oligodendrocytes (OLs) is a multistep process that involves largescale morphological changes with significant strain on the cytoskeleton. While key chromatin and transcriptional regulators of differentiation have been identified, their target genes responsible for the morphological changes occurring during OL myelination are still largely unknown. Here, we show that the regulator of focal adhesion, Tensin3 (Tns3), is a direct target gene of Olig2, Chd7, and Chd8, transcriptional regulators of OL differentiation. Tns3 is transiently upregulated and localized to cell processes of immature OLs, together with integrin-b1, a key mediator of survival at this transient stage. Constitutive Tns3 loss-of-function leads to reduced viability in mouse and humans, with surviving knockout mice still expressing Tns3 in oligodendroglia. Acute deletion of Tns3 in vivo, either in postnatal neural stem cells (NSCs) or in OPCs, leads to a two-fold reduction in OL numbers. We find that the transient upregulation of Tns3 is required to protect differentiating OPCs and immature OLs from cell death by preventing the upregulation of p53, a key regulator of apoptosis. Altogether, our findings reveal a specific time window during which transcriptional upregulation of Tns3 in immature OLs is required for OL differentiation likely by mediating integrin-b1 survival signaling to the actin cytoskeleton as OL undergo the large morphological changes required for their terminal differentiation.

Data availability

Sequencing data have been deposited in GEO under accession code GSE203295

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Emeric Merour

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  2. Hatem Hmidan

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  3. Corentine Marie

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  4. Pierre-Henri Helou

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  5. Haiyang Lu

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  6. Antoine Potel

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  7. Jean-Baptiste Hure

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  8. Adrien Clavairoly

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  9. Yi Ping Shih

    Department of Biochemistry and Molecular Medicine, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
  10. Salman Goudarzi

    School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  11. Sebastien Dussaud

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-5365-8338
  12. philippe Ravassard

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
  13. Sassan Hafizi

    School of Pharmacy and Biomedical Sciences, University of Portsmouth, Portsmouth, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-4539-0888
  14. Su Hao Lo

    Department of Biochemistry and Molecular Medicine, University of California, Davis, Davis, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2675-9387
  15. Bassem A Hassan

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9533-4908
  16. Carlos Parras

    Paris Brain Institute, Sorbonne Université, Inserm U1127, CNRS UMR 7225, Paris, France
    For correspondence
    carlos.parras@icm-institute.org
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0248-1752

Funding

National Multiple Sclerosis Society (NMSS RG-1501-02851)

  • Carlos Parras

Fondation pour l'Aide à la Recherche sur la Sclérose en Plaques (ARSEP 2014,2015,2018,2019,2020)

  • Corentine Marie

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Klaus-Armin Nave, Max Planck Institute of Experimental Medicine, Germany

Ethics

Animal experimentation: All animal procedures were performed according to the guidelines and regulations of the Inserm ethical committees (authorization #A75-13-19) and animal experimentation license A75-17-72

Version history

  1. Preprint posted: February 27, 2022 (view preprint)
  2. Received: May 15, 2022
  3. Accepted: June 27, 2022
  4. Accepted Manuscript published: October 10, 2022 (version 1)
  5. Version of Record published: October 25, 2022 (version 2)

Copyright

© 2022, Merour et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,016
    Page views
  • 225
    Downloads
  • 2
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Emeric Merour
  2. Hatem Hmidan
  3. Corentine Marie
  4. Pierre-Henri Helou
  5. Haiyang Lu
  6. Antoine Potel
  7. Jean-Baptiste Hure
  8. Adrien Clavairoly
  9. Yi Ping Shih
  10. Salman Goudarzi
  11. Sebastien Dussaud
  12. philippe Ravassard
  13. Sassan Hafizi
  14. Su Hao Lo
  15. Bassem A Hassan
  16. Carlos Parras
(2022)
Transient regulation of focal adhesion via Tensin3 is required for nascent oligodendrocyte differentiation
eLife 11:e80273.
https://doi.org/10.7554/eLife.80273

Share this article

https://doi.org/10.7554/eLife.80273

Further reading

    1. Developmental Biology
    2. Neuroscience
    Kristine B Walhovd, Stine K Krogsrud ... Didac Vidal-Pineiro
    Research Article

    Human fetal development has been associated with brain health at later stages. It is unknown whether growth in utero, as indexed by birth weight (BW), relates consistently to lifespan brain characteristics and changes, and to what extent these influences are of a genetic or environmental nature. Here we show remarkably stable and lifelong positive associations between BW and cortical surface area and volume across and within developmental, aging and lifespan longitudinal samples (N = 5794, 4–82 y of age, w/386 monozygotic twins, followed for up to 8.3 y w/12,088 brain MRIs). In contrast, no consistent effect of BW on brain changes was observed. Partly environmental effects were indicated by analysis of twin BW discordance. In conclusion, the influence of prenatal growth on cortical topography is stable and reliable through the lifespan. This early-life factor appears to influence the brain by association of brain reserve, rather than brain maintenance. Thus, fetal influences appear omnipresent in the spacetime of the human brain throughout the human lifespan. Optimizing fetal growth may increase brain reserve for life, also in aging.

    1. Developmental Biology
    2. Immunology and Inflammation
    Amir Hossein Kayvanjoo, Iva Splichalova ... Elvira Mass
    Research Article Updated

    During embryogenesis, the fetal liver becomes the main hematopoietic organ, where stem and progenitor cells as well as immature and mature immune cells form an intricate cellular network. Hematopoietic stem cells (HSCs) reside in a specialized niche, which is essential for their proliferation and differentiation. However, the cellular and molecular determinants contributing to this fetal HSC niche remain largely unknown. Macrophages are the first differentiated hematopoietic cells found in the developing liver, where they are important for fetal erythropoiesis by promoting erythrocyte maturation and phagocytosing expelled nuclei. Yet, whether macrophages play a role in fetal hematopoiesis beyond serving as a niche for maturing erythroblasts remains elusive. Here, we investigate the heterogeneity of macrophage populations in the murine fetal liver to define their specific roles during hematopoiesis. Using a single-cell omics approach combined with spatial proteomics and genetic fate-mapping models, we found that fetal liver macrophages cluster into distinct yolk sac-derived subpopulations and that long-term HSCs are interacting preferentially with one of the macrophage subpopulations. Fetal livers lacking macrophages show a delay in erythropoiesis and have an increased number of granulocytes, which can be attributed to transcriptional reprogramming and altered differentiation potential of long-term HSCs. Together, our data provide a detailed map of fetal liver macrophage subpopulations and implicate macrophages as part of the fetal HSC niche.